EP0966472A4 - - Google Patents

Info

Publication number
EP0966472A4
EP0966472A4 EP97950724A EP97950724A EP0966472A4 EP 0966472 A4 EP0966472 A4 EP 0966472A4 EP 97950724 A EP97950724 A EP 97950724A EP 97950724 A EP97950724 A EP 97950724A EP 0966472 A4 EP0966472 A4 EP 0966472A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP97950724A
Other versions
EP0966472A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0966472A1 publication Critical patent/EP0966472A1/en
Publication of EP0966472A4 publication Critical patent/EP0966472A4/xx
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97950724A 1996-11-27 1997-11-21 Cephalosporin derivatives Ceased EP0966472A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3404696P 1996-11-27 1996-11-27
US34046P 1996-11-27
PCT/US1997/021785 WO1998023621A1 (en) 1996-11-27 1997-11-21 Cephalosporin derivatives

Publications (2)

Publication Number Publication Date
EP0966472A1 EP0966472A1 (en) 1999-12-29
EP0966472A4 true EP0966472A4 (it) 1999-12-29

Family

ID=21873971

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97950724A Ceased EP0966472A1 (en) 1996-11-27 1997-11-21 Cephalosporin derivatives

Country Status (17)

Country Link
EP (1) EP0966472A1 (it)
JP (1) JP2001506607A (it)
KR (1) KR20000057283A (it)
CN (1) CN1238775A (it)
AR (1) AR010650A1 (it)
AU (1) AU734948B2 (it)
BR (1) BR9713350A (it)
CA (1) CA2272717A1 (it)
CZ (1) CZ185399A3 (it)
HU (1) HUP9903621A3 (it)
IL (1) IL129437A0 (it)
NO (1) NO992526L (it)
NZ (1) NZ335892A (it)
PL (1) PL334558A1 (it)
TW (1) TW414796B (it)
WO (1) WO1998023621A1 (it)
ZA (1) ZA9710662B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265394B1 (en) * 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
KR20140034798A (ko) * 2011-05-18 2014-03-20 신젠타 파티서페이션즈 아게 아릴티오아세트아미드 유도체에 기반한 살곤충 화합물
CN105131018B (zh) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 一种头孢替唑酸的制备方法
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
GB2007221A (en) * 1977-11-07 1979-05-16 Yeda Res & Dev 7-sulphomethyl phenyl acetamidocephalsporin derivatives
EP0727426A2 (en) * 1995-02-15 1996-08-21 Bristol-Myers Squibb Company Cephalosporin derivatives
WO1997022611A1 (en) * 1995-12-20 1997-06-26 Bristol-Myers Squibb Company Cephalosporin derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620969A (en) * 1995-04-25 1997-04-15 Bristol-Myers Squibb Company Cephalosporin derviatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
GB2007221A (en) * 1977-11-07 1979-05-16 Yeda Res & Dev 7-sulphomethyl phenyl acetamidocephalsporin derivatives
EP0727426A2 (en) * 1995-02-15 1996-08-21 Bristol-Myers Squibb Company Cephalosporin derivatives
WO1997022611A1 (en) * 1995-12-20 1997-06-26 Bristol-Myers Squibb Company Cephalosporin derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9823621A1 *

Also Published As

Publication number Publication date
AR010650A1 (es) 2000-06-28
AU5365298A (en) 1998-06-22
NO992526D0 (no) 1999-05-26
IL129437A0 (en) 2000-02-17
EP0966472A1 (en) 1999-12-29
KR20000057283A (ko) 2000-09-15
NO992526L (no) 1999-05-26
NZ335892A (en) 2001-07-27
HUP9903621A3 (en) 2001-05-28
BR9713350A (pt) 2000-01-25
CN1238775A (zh) 1999-12-15
AU734948B2 (en) 2001-06-28
CZ185399A3 (cs) 1999-08-11
TW414796B (en) 2000-12-11
PL334558A1 (en) 2000-03-13
JP2001506607A (ja) 2001-05-22
CA2272717A1 (en) 1998-06-04
HUP9903621A2 (hu) 2000-04-28
ZA9710662B (en) 1999-05-26
WO1998023621A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
IN191433B (it)
IN192452B (it)
IN190446B (it)
ITMI960378A0 (it)
IN191378B (it)
ITMI960222A0 (it)
ITMI960306A0 (it)
ITMC960034V0 (it)
ITCO960024V0 (it)
IN186191B (it)
IN188300B (it)
ITMI960516V0 (it)
ECSDI960374S (it)
CN3047249S (it)
CN3046158S (it)
CN3047647S (it)
CN3047648S (it)
CN3047597S (it)
CN3047495S (it)
CN3047494S (it)
CN3047493S (it)
CN3047348S (it)
CN3047312S (it)
CN3047252S (it)
CN3047496S (it)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990518

A4 Supplementary search report drawn up and despatched

Effective date: 19991007

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20001006

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20020117

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1023569

Country of ref document: HK